Syndax Pharmaceuticals(DE:1T3)
€8.21-0.25 (-2.95%)
DE:1T3
Syndax Pharmaceuticals earnings date
€8.21
At close:-0.25 (-2.95%)
Syndax Pharmaceuticals (1T3) Q4 2023 Earnings Report
4 Followers
DE:1T3 Q4 2023 EPS Results
- Actual EPS
- -EUR 0.91
- Consensus EPS
- -EUR 0.88
- Beat/Miss
- Missed by -EUR 0.03
- One Year Ago EPS
- -EUR 0.57
DE:1T3 Q4 2023 Revenue Results
- Actual Revenue
- EUR 0
- Expected Revenue
- EUR 0
- Beat/Miss
- Met expectations
- YoY Revenue Growth
- ―
Earnings Announcement Details
- Quarter
- Q4 2023
- Date
- 02/27/2024
- Time
- After Close
- Conference Call
- Tuesday, February 27, 2024
DE:1T3 Upcoming Earnings
Syndax Pharmaceuticals's next earnings date is estimated for March 2, 2027, based on past reporting schedules.
Q4 2023 Earnings Call Audio
DE:1T3 Q4 2023 Earnings Call
0:00 / 0:00
Q4 2023 Earnings Slide Deck
Q4 2023 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:1T3 Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 02, 2027 | 2026 (Q4) | -0.44- | -0.71 | ― | ― |
| Nov 02, 2026 | 2026 (Q3) | -0.46-0.50 | -0.64 | 21.43% (+0.14) | |
| Aug 04, 2026 | 2026 (Q2) | -0.41-0.50 | -0.76 | 33.73% (+0.26) | |
| Apr 30, 2026 | 2026 (Q1) | -0.55-0.44 | -0.89 | 51.02% (+0.46) | |
| Feb 26, 2026 | 2025 (Q4) | -0.53-0.71 | -1 | 29.09% (+0.29) | |
| Nov 03, 2025 | 2025 (Q3) | -0.66-0.64 | -0.89 | 28.57% (+0.26) | |
| Aug 04, 2025 | 2025 (Q2) | -0.93-0.76 | -0.73 | -3.75% (-0.03) | |
| May 05, 2025 | 2025 (Q1) | -1.14-0.89 | -0.77 | -15.29% (-0.12) | |
| Mar 03, 2025 | 2024 (Q4) | -0.76-1.00 | -0.91 | -10.00% (-0.09) | |
| Nov 05, 2024 | 2024 (Q3) | -0.98-0.89 | -0.67 | -34.25% (-0.23) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed


